Citations (179)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Hacene Bendjeffal, Mounir Ziati, Amel Aloui, Hadjer Mamine, Toufek Metidji, Abdelkrim Djebli & Yacine Bouhedja. (2023) Adsorption and removal of hydroxychloroquine from aqueous media using Algerian kaolin: Full factorial optimisation, kinetic, thermodynamic, and equilibrium studies. International Journal of Environmental Analytical Chemistry 103:9, pages 1982-2003.
Read now
Read now
Axel Hage, Mathis de Vries, Andreas Leffler & Carsten Stoetzer. (2022) Local Anesthetic Like Inhibition of the Cardiac Na+ Channel Nav1.5 by Chloroquine and Hydroxychloroquine. Journal of Experimental Pharmacology 14, pages 353-365.
Read now
Read now
Toussaint Rouamba, Houreratou Barry, Esperance Ouédraogo, Marc Christian Tahita, Nobila Valentin Yaméogo, Armel Poda, Arnaud Eric Diendéré, Abdoul-Salam Ouedraogo, Innocent Valea, Amariane M Koné, Cherileila Thiombiano, Isidore Traoré, Zekiba Tarnagda, Serge A Sawadogo, Zakaria Gansané, Yibar Kambiré, Idrissa Sanou, Fatou Barro-Traoré, Maxime K Drabo & Halidou Tinto. (2021) Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study. Therapeutics and Clinical Risk Management 17, pages 1187-1198.
Read now
Read now
Sultan A M Saghir, Naif A AlGabri, Mahmoud M Alagawany, Youssef A Attia, Salem R Alyileili, Shaaban S Elnesr, Manal E Shafi, Omar Y A Al-shargi, Nader Al-balagi, Abdullah S Alwajeeh, Omar S A Alsalahi, Amlan K Patra, Asmaa F Khafaga, Ahmed Negida, Ahmed Noreldin, Wesam Al-Amarat, Amer A Almaiman, Khaled A El-Tarabily & Mohamed E Abd El-Hack. (2021) Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review. Therapeutics and Clinical Risk Management 17, pages 371-387.
Read now
Read now
Musim Alotaibi, Ahmed Ali, Duaa Bakhshwin, Yasser Alatawi, Sultan Alotaibi, Abdullah Alhifany, Badr Alharthi, Nasser Alharthi, Awatef Alyazidi, Yasmeen Alharthi & Aziza Alrafiah. (2021) Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study. International Journal of General Medicine 14, pages 5597-5606.
Read now
Read now
Taihei Nishiyama, Yuya Kondo, Hiroto Tsuboi, Hisashi Noma, Daiki Tabuchi, Toshiki Sugita, Shota Okamoto, Toshihiko Terasaki, Masaru Shimizu, Fumika Honda, Ayako Ohyama, Izumi Kurata, Mizuki Yagishita, Saori Abe, Hiroyuki Takahashi, Atsumu Osada, Shinya Hagiwara, Isao Matsumoto & Takayuki Sumida. (2021) QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine. Modern Rheumatology 31:6, pages 1107-1112.
Read now
Read now
Marco Infante, Camillo Ricordi, Rodolfo Alejandro, Massimiliano Caprio & Andrea Fabbri. (2021) Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Expert Review of Anti-infective Therapy 19:1, pages 5-16.
Read now
Read now
Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay & Mohamed Gomaa Kamel. (2020) Possible therapeutic agents for COVID-19: a comprehensive review. Expert Review of Anti-infective Therapy 18:10, pages 1005-1020.
Read now
Read now
Ernst Tönnesmann, Reinhard Kandolf & Thorsten Lewalter. (2013) Chloroquine cardiomyopathy – a review of the literature. Immunopharmacology and Immunotoxicology 35:3, pages 434-442.
Read now
Read now
Articles from other publishers (170)
Michelle Vanessa Kamga Kapchoup, Jürgen Hescheler & Filomain Nguemo. (2023) In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives. Frontiers in Pharmacology 14.
Crossref
Crossref
Mercedes E. Quiñones, Joyce K. Joseph, Sharon Dowell, Hans J. Moore, Pamela E. Karasik, Gregg C. Fonarow, Ross D. Fletcher, Yan Cheng, Qing Zeng‐Treitler, Cherinne Arundel, Angelike P. Liappis, Helen M. Sheriff, Sijian Zhang, Daniel D. Taub, Michael S. Heimall, Charles Faselis, Gail S. Kerr & Ali Ahmed. (2023)
Hydroxychloroquine and Risk of Long
QT
Syndrome in Rheumatoid Arthritis: A Veterans Cohort Study With
Nineteen‐Year
Follow‐up
. Arthritis Care & Research 75:7, pages 1571-1579.
Crossref
Crossref
Fernando Guerrero-Romero, Oliver Micke, Luis E. Simental-Mendía, Martha Rodríguez-Morán, Juergen Vormann, Stefano Iotti, Nikolina Banjanin, Andrea Rosanoff, Shadi Baniasadi, Guitti Pourdowlat & Mihai Nechifor. (2023) Importance of Magnesium Status in COVID-19. Biology 12:5, pages 735.
Crossref
Crossref
Rui-Jian Jiang, Juan Jia, Yong Du & Hai-Song Zhang. (2023) Sinus bradycardia and heart failure induced by short-term use of low-dose hydroxychloroquine: A case report. Asian Journal of Surgery 46:4, pages 1594-1595.
Crossref
Crossref
Anju Manuja, Dharvi Chhabra & Balvinder Kumar. (2023) Chloroquine chaos and COVID-19: Smart delivery perspectives through pH sensitive polymers/micelles and ZnO nanoparticles. Arabian Journal of Chemistry 16:2, pages 104468.
Crossref
Crossref
Xiqiang Wang, Yunfei Feng, Senmiao Liu, Jing Liu, Shuo Pan, Linyan Wei, Yanpeng Ma, Zhongwei Liu, Yujie Xing, Junkui Wang, Qianwei Cui, Yong Zhang, Tingzhong Wang & Chuipu Cai. (2023) Hydroxychloroquine Attenuates hERG Channel by Promoting the Membrane Channel Degradation: Computational Simulation and Experimental Evidence for QT-Interval Prolongation with Hydroxychloroquine Treatment. Cardiology 148:4, pages 310-323.
Crossref
Crossref
H Michael Belmont & Mayce Haj-Ali. (2023) Whole blood drug levels do not correlate with QTc intervals in hydroxychloroquine-treated systemic lupus erythematosus patients. Rheumatology 62:1, pages 450-456.
Crossref
Crossref
Rosemeire M. Kanashiro-Takeuchi, Katarzyna Kazmierczak, Jingsheng Liang, Lauro M. Takeuchi, Yoel H. Sitbon & Danuta Szczesna-Cordary. (2022) Hydroxychloroquine Mitigates Dilated Cardiomyopathy Phenotype in Transgenic D94A Mice. International Journal of Molecular Sciences 23:24, pages 15589.
Crossref
Crossref
Hui Xue, Yuexin Li, Zhengrong Zhao, Jiacheng Ren, Wenting Yu, Fang Wang, Xianghua Li, Jiaxin Li, Qianqian Xia, Yuxin Zhang & Baoxin Li. (2022) Deacetylation mechanism and potential reversal strategy of long QT syndrome on hERG K+ channel under hypoxia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:11, pages 166487.
Crossref
Crossref
Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Lindsey R Baden, Vincent Chi-Chung Cheng, Kathryn M Edwards, Jason C Gallagher, Rajesh T Gandhi, William J Muller, Mari M Nakamura, John C O’Horo, Robert W Shafer, Shmuel Shoham, M Hassan Murad, Reem A Mustafa, Shahnaz Sultan & Yngve Falck-Ytter. (2022) Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases.
Crossref
Crossref
Chien Hsien Lo, Yu-Hsun Wang, Chin Feng Tsai, Kuei Chuan Chan, Li Ching Li, Tse Hsien Lo, Chun Hung Su & James Cheng-Chung Wei. (2022)
Correspondence on ‘
Festina lente
: hydroxychloroquine, COVID-19 and the role of the rheumatologist’ by Graef
et al
. Annals of the Rheumatic Diseases 81:9, pages e163-e163.
Crossref
Crossref
Lorenzo Villa Zapata, Richard D. Boyce, Eric Chou, Philip D. Hansten, John R. Horn, Sheila M. Gephart, Vignesh Subbian, Andrew Romero & Daniel C. Malone. (2022) QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data. Drugs - Real World Outcomes 9:3, pages 415-423.
Crossref
Crossref
Mohammed Ahmed Akkaif, Abubakar Sha’aban, Arturo Cesaro, Ammar Ali Saleh Jaber, Andrea Vergara, Ismaeel Yunusa, Abubakar Ibrahim Jatau, Mustapha Mohammed, G. Saravana Govindasamy, Majed Ahmed Al-Mansoub, Muhamad Ali Sheikh Abdul Kader & Baharudin Ibrahim. (2022) The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review. Inflammopharmacology 30:4, pages 1143-1151.
Crossref
Crossref
Gianni Testino, Teo Vignoli, Valentino Patussi, Pierluigi Allosio, Maria Francesca Amendola, Sarino Aricò, Aniello Baselice, Patrizia Balbinot, Vito Campanile, Tiziana Fanucchi, Giovanni Greco, Livia Macciò, Cristina Meneguzzi, Davide Mioni, Vincenzo Ostilio Palmieri, Michele Parisi, Doda Renzetti, Raffaella Rossin, Claudia Gandin, Luigi Carlo Bottaro, Mauro Bernardi, Giovanni Addolorato, Lisa Lungaro, Giorgio Zoli, Emanuele Scafato & Fabio Caputo. (2021) Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Digestive Diseases and Sciences 67:6, pages 1975-1986.
Crossref
Crossref
A. Weber & W. Rabl. (2021) Kombinierter Suizid: Methode nach Kusch und Kopfschuss – ein FallberichtCombined suicide: method of Kusch and gunshot to the head – a case report. Rechtsmedizin 32:3, pages 212-216.
Crossref
Crossref
Fabiola Atzeni, Francesco Gozza, Giacomo Cafaro, Carlo Perricone & Elena Bartoloni. (2022) Cardiovascular Involvement in Sjögren’s Syndrome. Frontiers in Immunology 13.
Crossref
Crossref
Ahmed E. Abou Warda, Mahmoud Tammam, Rabab A. El-Gazar, Rania M. Sarhan & Sayed Gaber. (2022) Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges. Current Drug Safety 17:2, pages 143-151.
Crossref
Crossref
Ajar KOÇAK, Ayhan COŞGUN, Dilek KARAMANLIOĞLU & Mustafa Hamidullah TÜRKKANI. (2022) The effects of combined hydroxychloroquine and azithromycin therapy on QRS wave in COVID-19 patients. Journal of Surgery and Medicine 6:4, pages 483-487.
Crossref
Crossref
Yehuda Wexler & Udi Nussinovitch. (2021) Repolarization in systemic sclerosis: a meta-analysis. Clinical Rheumatology 41:4, pages 1131-1137.
Crossref
Crossref
Srinivasan Jayaraman & Ponnuraj Kirthi Priya. 2022. Cardiac Arrhythmias - Translational Approach from Pathophysiology to Advanced Care. Cardiac Arrhythmias - Translational Approach from Pathophysiology to Advanced Care.
Wener Li, Xiaojing Luo, Mareike S. Poetsch, Reinhard Oertel, Kapil Nichani, Martin Schneider, Anna Strano, Marcel Hasse, Robert-Patrick Steiner, Lukas Cyganek, Karina Hettwer, Steffen Uhlig, Kirsten Simon, Kaomei Guan & Mario Schubert. (2022) Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration. Pharmaceuticals 15:2, pages 220.
Crossref
Crossref
Gianni Testino, Teo Vignoli, Valentino Patussi, Pierluigi Allosio, Maria Francesca Amendola, Sarino Aricò, Aniello Baselice, Patrizia Balbinot, Vito Campanile, Tiziana Fanucchi, Livia Macciò, Cristina Meneguzzi, Davide Mioni, Michele Parisi, Doda Renzetti, Raffaella Rossin, Claudia Gandin, Luigi Carlo Bottaro, Giacomo Caio, Lisa Lungaro, Giorgio Zoli, Emanuele Scafato & Fabio Caputo. (2021) Alcohol use disorder in the COVID‐19 era: Position paper of the Italian Society on Alcohol (SIA). Addiction Biology 27:1.
Crossref
Crossref
Avinash Kumar, Arpana Parihar, S. Nisar Basha & Udwesh Panda. 2022. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection
451
488
.
Kristen Bova Campbell. 2022. Torsades de Pointes. Torsades de Pointes
231
266
.
Pietro Enea Lazzerini, Franco Laghi-Pasini, Pier Leopoldo Capecchi & Mohamed Boutjdir. 2022. Torsades de Pointes. Torsades de Pointes
113
156
.
José Alexandre Salerno, Thayana Torquato, Jairo R. Temerozo, Livia Goto-Silva, Karina Karmirian, Mayara A. Mendes, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Letícia R Q. Souza, Isis M. Ornelas, Carla P. Veríssimo, Luiz Guilherme H S. Aragão, Gabriela Vitória, Carolina S G. Pedrosa, Suelen da Silva Gomes Dias, Vinicius Cardoso Soares, Teresa Puig-Pijuan, Vinícius Salazar, Rafael Dariolli, Diogo Biagi, Daniel R. Furtado, Luciana Barreto Chiarini, Helena L. Borges, Patrícia T. Bozza, Marilia Zaluar P. Guimarães, Thiago M.L. Souza & Stevens K. Rehen. (2021) Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating. PeerJ 9, pages e12595.
Crossref
Crossref
R. O. Kantariya, Ya. G. Moysyuk, E. I. Prokopenko, A. R. Karapityan, A. A. Ammosov, A. V. Makevnina & A. A. Gaydarova. (2021) Clinical characteristics and outcomes of COVID-19 in kidney transplant recipients. Transplantologiya. The Russian Journal of Transplantation 13:4, pages 339-355.
Crossref
Crossref
Francesco Santoro, Francesco Monitillo, Pasquale Raimondo, Agostino Lopizzo, Gaetano Brindicci, Michele Gilio, Francesco Musaico, Michele Mazzola, Domenico Vestito, Rossella Di Benedetto, Mohammad Abumayyaleh, Ibrahim El-Battrawy, Carmen Rita Santoro, Luigi Flavio Massimiliano Di Martino, Ibrahim Akin, Giulio De Stefano, Rosario Fiorilli, Michele Cannone, Annalisa Saracino, Salvatore Angarano, Sergio Carbonara, Salvatore Grasso, Luigi Di Biase & Natale Daniele Brunetti. (2021) QTc Interval Prolongation and Life-Threatening Arrhythmias During Hospitalization in Patients With Coronavirus Disease 2019 (COVID-19): Results From a Multicenter Prospective Registry. Clinical Infectious Diseases 73:11, pages e4031-e4038.
Crossref
Crossref
Anıl Ucan, Pamir Cerci, Serdar Efe, Hakan Akgun, Ahmet Ozmen, Aysel Yagmuroglu, Muzaffer Bilgin & Deniz Avci. (2021) Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study. Virology Journal 18:1.
Crossref
Crossref
Nessaibia Issam, Tichati Lazhari, Bouarroudj Tayeb, Siciliano Dafne, Bouslama Zihad, Merad Tarek & Tahraoui Abdelkrim. (2021) Mécanismes possiblement impliqués dans les effets antiviraux de la chloroquine et de l’hydroxychloroquine – Quelle réalité pour le traitement de la COVID-19 ?. Toxicologie Analytique et Clinique 33:4, pages 237-247.
Crossref
Crossref
Julianna Desmarais, James T. Rosenbaum, Karen H. Costenbader, Ellen M. Ginzler, Nicole Fett, Susan Goodman, James O’Dell, Christian A. Pineau, Gabriela Schmajuk, Victoria P. Werth, Mark S. Link & Richard Kovacs. (2021) American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity. Arthritis & Rheumatology 73:12, pages 2151-2160.
Crossref
Crossref
Shagufta & Irshad Ahmad. (2021) An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS‐CoV‐2 Activity. ChemistrySelect 6:42, pages 11502-11527.
Crossref
Crossref
Ankur Gupta, Anish Pradhan, Vimal K. Maurya, Swatantra Kumar, Angila Theengh, Bipin Puri & Shailendra K. Saxena. (2021) Therapeutic approaches for SARS-CoV-2 infection. Methods 195, pages 29-43.
Crossref
Crossref
Ponnuraj Kirthi Priya & Srinivasan Jayaraman. (2021) Does the influence of hydroxychloroquine in a hypoxic ventricle differ from that of a non-hypoxic ventricle under congenital LQTS1 ?. Does the influence of hydroxychloroquine in a hypoxic ventricle differ from that of a non-hypoxic ventricle under congenital LQTS1 ?.
Veysel Yavuz, Ferhat Ozyurtlu & Nurullah Cetin. (2021) Comparison of hydroxychloroquine plus moxifloxacin versus hydroxychloroquine alone on corrected QT interval prolongation in COVID-19 patients. Cor et Vasa 63:5, pages 564-571.
Crossref
Crossref
. (2021) Hydroxychloroquine- and Azithromycin-Induced
Transient Left-Bundle Branch Block in a Patient with
COVID-19. EMJ Cardiology, pages 92-97.
Crossref
Crossref
Ponnuraj Kirthi Priya & Srinivasan Jayaraman. (2021) Hydroxychloroquine's Influence on Hypoxic and Hypokalemic ventricle: An Insilico Perspective. Hydroxychloroquine's Influence on Hypoxic and Hypokalemic ventricle: An Insilico Perspective.
Matt K. Smith, Ravil Bikmetov, Sweilem B. Al Rihani, Malavika Deodhar, Matthew Hafermann, Pamela Dow, Jacques Turgeon & Veronique Michaud. (2021) Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study. Clinical and Translational Science 14:5, pages 1799-1809.
Crossref
Crossref
Wei Zhao, Nikhil Gandhi, Saif Affas, Susan Szpunar, Nancy Mesiha & Louis Saravolatz. (2021) Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection. Annals of Noninvasive Electrocardiology 26:5.
Crossref
Crossref
Israa A. Seliem, Siva S. Panda, Adel S. Girgis, Yassmin Moatasim, Ahmed Kandeil, Ahmed Mostafa, Mohamed A. Ali, Eman S. Nossier, Fatma Rasslan, Aladdin M. Srour, Rajeev Sakhuja, Tarek S. Ibrahim, Zakaria K.M. Abdel-samii & Amany M.M. Al-Mahmoudy. (2021) New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2. Bioorganic Chemistry 114, pages 105117.
Crossref
Crossref
Hasan Ali Barman, Adem Atici, Gokhan Alici, Omer Sit, Sevil Tugrul, Baris Gungor, Ertugrul Okuyan & Irfan Sahin. (2021) The effect of the severity COVID-19 infection on electrocardiography. The American Journal of Emergency Medicine 46, pages 317-322.
Crossref
Crossref
Jérôme Montnach, Isabelle Baró, Flavien Charpentier, Michel De Waard & Gildas Loussouarn. (2021) Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case. EP Europace 23:7, pages 1124-1133.
Crossref
Crossref
Nicholas Kassis, Christine Tanaka-Esposito, Roy Chung, Ankur Kalra, Mingyuan Shao, Ashish Kumar, Jafar Alzubi, Mina K. Chung & Umesh N. Khot. (2021) Validating and implementing cardiac telemetry for continuous QTc monitoring: A novel approach to increase healthcare personnel safety during the COVID-19 pandemic. Journal of Electrocardiology 67, pages 1-6.
Crossref
Crossref
C. T. Dhanya Raj, Dinesh Kumar Kandaswamy, Ravi Chandra Sekhara Reddy Danduga, Raju Rajasabapathy & Rathinam Arthur James. (2021) COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review. Archives of Microbiology 203:5, pages 2043-2057.
Crossref
Crossref
Raffaele Costa, Alberto Castagna, Carlo Torchia, Carmen Ruberto, Viviana Vespertini, Lucio Cosco & Giovanni Ruotolo. (2021) Proarrhythmia assessment in treatment with hydroxychloroquine and azithromycin hospitalized elderly COVID-19 patients - our experience. Geriatric Care 7:2.
Crossref
Crossref
Shuo Ning, Beiming Yu, Yanfeng Wang & Feng Wang. (2021) SARS-CoV-2: Origin, Evolution, and Targeting Inhibition. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Carlos Minguito-Carazo, Julio Echarte-Morales, Tomás Benito-González, Samuel Del Castillo-García, Miguel Rodríguez-Santamarta, Enrique Sánchez-Muñoz, Clea González Maniega, Rubén García-Bergel, Paula Menéndez-Suárez, Silvia Prieto-González, Carmen Palacios-Echavarren, Javier Borrego-Rodríguez, Guisela Flores-Vergara, Ignacio Iglesias-Garriz & Felipe Fernández-Vázquez. (2021) QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients. Global Heart 16:1, pages 42.
Crossref
Crossref
Alisha Gupta, Kelly J. Shields, Susan Manzi, Mary Chester Wasko & Tarun S. Sharma. (2021) Association of Hydroxychloroquine Use With Decreased Incident Atrial Fibrillation in Systemic Lupus Erythematosus. Arthritis Care & Research 73:6, pages 828-832.
Crossref
Crossref
Julianna Desmarais & Mark S. Link. (2021) Hydroxychloroquine: Not a Heart Breaker!. Arthritis Care & Research 73:6, pages 770-771.
Crossref
Crossref
Christina Chuong, Christine M. DuChane, Emily M. Webb, Pallavi Rai, Jeffrey M. Marano, Chad M. Bernier, Joseph S. Merola & James Weger-Lucarelli. (2021) Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2. Viruses 13:6, pages 980.
Crossref
Crossref
Chien-Hsien Lo, Yu-Hsun Wang, Chin-Feng Tsai, Kuei-Chuan Chan, Li-Ching Li, Tse-Hsien Lo, James Cheng-Chung Wei & Chun-Hung Su. (2021) Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study. PLOS ONE 16:5, pages e0251918.
Crossref
Crossref
Urooba Nadeem, Muhammad Raafey, Gene Kim, Jerermy Treger, Peter Pytel, Aliya N Husain & Jefree J Schulte. (2021) Chloroquine- and Hydroxychloroquine–Induced Cardiomyopathy: A Case Report and Brief Literature Review. American Journal of Clinical Pathology 155:6, pages 793-801.
Crossref
Crossref
Teddy S. Ehianeta, Richard O. Akinyeye, Joshua I. Orege, Onome Ejeromedoghene, Adeniyi P. Adebule & Bright O. Okonkwo. (2021) Old drugs for a new indication: a review of chloroquine and analogue in COVID-19 treatment. Porto Biomedical Journal 6:3, pages e132.
Crossref
Crossref
Pierre Jordaan, Bérengère Dumotier, Martin Traebert, Paul E Miller, Andre Ghetti, Laszlo Urban & Najah Abi-Gerges. (2021) Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes. Toxicological Sciences 180:2, pages 356-368.
Crossref
Crossref
Chien-Hsien Lo, James Cheng-Chung Wei, Yu-Hsun Wang, Chin-Feng Tsai, Kuei-Chuan Chan, Li-Ching Li, Tse-Hsien Lo & Chun-Hung Su. (2021) Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study. Frontiers in Immunology 12.
Crossref
Crossref
Maitri M. Patel, Dhruvkumar M. Patel, Mukundkumar V. Patel, Jayanti K. Gurumukhani, Suyog Y Patel & Harsh D. Patel. (2021) Hydroxychloroquine Induced DRESS (Drug Rash with Eosinophilia and Systemic Symptoms Syndrome) Mimicking SARS-COV-2 Illness: A Case Report with Review. Coronaviruses 2:4, pages 521-526.
Crossref
Crossref
Gayathri Baburaj, Levin Thomas & Mahadev Rao. (2021) Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies. Archives of Medical Research 52:3, pages 261-269.
Crossref
Crossref
Wen-Liang Yu, Han Siong Toh, Chia-Te Liao & Wei-Ting Chang. (2020) A Double-Edged Sword—Cardiovascular Concerns of Potential Anti-COVID-19 Drugs. Cardiovascular Drugs and Therapy 35:2, pages 205-214.
Crossref
Crossref
Lucie Pothen, Halil Yildiz, Mathilde Mbouck Samnick & Jean Cyr Yombi. (2021) Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?. Clinical Rheumatology 40:4, pages 1649-1657.
Crossref
Crossref
Okechukwu S. Ogah, Ejiroghene M. Umuerri, Adewole Adebiyi, Olanike A. Orimolade, Mahmoud U. Sani, Dike B. Ojji, Amam C. Mbakwem, Simon Stewart & Karen Sliwa. (2021) SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications. Global Heart 16:1.
Crossref
Crossref
Andrea Matteucci, Gianluca Massaro, Domenico Sergi, Michela Bonanni, Giuseppe Stifano, Matteo Matino, Bartolomeo Zerillo, Paola Rogliani & Francesco Romeo. (2021) Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort. Journal of Cardiovascular Medicine 22:3, pages 190-196.
Crossref
Crossref
Waqas Aslam, Carla R Lamb & Nadia Ali. (2021) Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications. BMJ Case Reports 14:3, pages e239963.
Crossref
Crossref
Shagufta & Irshad Ahmad. (2021) The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2. European Journal of Medicinal Chemistry 213, pages 113157.
Crossref
Crossref
Alberto Castagna, Giovanni Ruotolo & Ciro Manzo. (2020) Progress in the risk assessment of hydroxychloroquine in frail elderly people. AGING MEDICINE 4:1, pages 53-57.
Crossref
Crossref
Matteo Bianco, Carlo Alberto Biolè & Enrico Cerrato. (2021) QT Interval in Patients With COVID-19. JAMA Cardiology 6:3, pages 357.
Crossref
Crossref
Stephani Correia Brazão, Lis Jappour Autran, Rosane de Oliveira Lopes, Christianne Brêtas Vieira Scaramello, Fernanda Carla Ferreira de Brito & Nadia Alice Vieira Motta. (2021) Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19. International Journal of Cardiovascular Sciences.
Crossref
Crossref
Miao Zhang, Xueting Yao, Zhe Hou, Xuan Guo, Siqi Tu, Zihan Lei, Zhiheng Yu, Xuanlin Liu, Cheng Cui, Xijing Chen, Ning Shen, Chunli Song, Jie Qiao, Xiaoqiang Xiang, Haiyan Li & Dongyang Liu. (2021) Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients. Frontiers in Pharmacology 11.
Crossref
Crossref
Puneet K. Samaiya & Mahendra Kumar. (2021) SARS-CoV-2 Therapy: Old Drugs as New Interventions. Coronaviruses 2:2, pages 142-150.
Crossref
Crossref
İbrahim Halil Özdemir, Bülent Özlek, Mehmet Burak Özen, Ramazan Gündüz, Nurullah Çetin & Ali Rıza Bilge. (2020) Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID‐19. International Journal of Clinical Practice 75:2.
Crossref
Crossref
Amir Sarayani, Brian Cicali, Carl H. Henriksen & Joshua D. Brown. (2021) Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. Research in Social and Administrative Pharmacy 17:2, pages 483-486.
Crossref
Crossref
Imad M. Tleyjeh, Zakariya Kashour, Oweida AlDosary, Muhammad Riaz, Haytham Tlayjeh, Musa A. Garbati, Rana Tleyjeh, Mouaz H. Al-Mallah, M. Rizwan Sohail, Dana Gerberi, Aref A. Bin Abdulhak, John R. Giudicessi, Michael J. Ackerman & Tarek Kashour. (2021) Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5:1, pages 137-150.
Crossref
Crossref
Andrea Bernardini, Giuseppe Ciconte, Gabriele Negro, Roberto Rondine, Valerio Mecarocci, Tommaso Viva, Francesca Santini, Carlo de Innocentiis, Luigi Giannelli, Ewa Witkowska, Emanuela Teresina Locati, Serenella Castelvecchio, Massimiliano M. Marrocco-Trischitta, Gabriele Vicedomini, Lorenzo Menicanti & Carlo Pappone. (2021) Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen. International Journal of Cardiology 324, pages 242-248.
Crossref
Crossref
Zheng Zequn, Wu Yujia, Qian Dingding & Lian Jiangfang. (2021) Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. European Journal of Pharmacology 893, pages 173813.
Crossref
Crossref
Hussain Ahmed Raza, Javeria Tariq, Vikas Agarwal & Latika Gupta. (2021) COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. Rheumatology International 41:2, pages 257-273.
Crossref
Crossref
Asim Kichloo, Michael Albosta, Akshay Kumar, Michael Aljadah, Mohamed Mohamed, Zain El-Amir, Farah Wani, Shakeel Jamal, Jagmeet Singh & Akif Kichloo. (2021) Emerging therapeutics in the management of COVID-19. World Journal of Virology 10:1, pages 1-29.
Crossref
Crossref
Gagan Priya, Shibba Takkar Chhabra & Sanjay Kalra. (2021) Rhythm Disorders in Endocrinology. European Journal of Arrhythmia & Electrophysiology 7:1, pages 12.
Crossref
Crossref
Yanting Yu, Jianteng Xu, Anni Xie, Sijia Liu, Xiaojian Wang, Runzhang Zhu & Xiaoyan Wang. (2021) Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases. Kidney Diseases 7:5, pages 401-410.
Crossref
Crossref
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali & Jacques Turgeon. (2020) Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs. Clinical and Translational Science 14:1, pages 20-28.
Crossref
Crossref
Heba Hussein & Ronald Brown. (2021) Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 131:1, pages e9-e13.
Crossref
Crossref
Thomas F. O’Connell, Christopher J. Bradley, Amr E. Abbas, Brian D. Williamson, Akash Rusia, Adam M. Tawney, Rick Gaines, Jason Schott, Alex Dmitrienko & David E. Haines. (2021) Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19. JACC: Clinical Electrophysiology 7:1, pages 16-25.
Crossref
Crossref
Atula Gupta, Dedee F. Murrell, James Otton & Mohamad Goldust. 2021. Skin and the Heart. Skin and the Heart
203
210
.
Catherine Gebhard, Vera Regitz-Zagrosek, Hannelore K. Neuhauser, Rosemary Morgan & Sabra L. Klein. (2020) Impact of sex and gender on COVID-19 outcomes in Europe. Biology of Sex Differences 11:1.
Crossref
Crossref
Michael Takla & Kamalan Jeevaratnam. (2020) Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety. Saudi Pharmaceutical Journal 28:12, pages 1760-1776.
Crossref
Crossref
Veronique M.M.M. Schiffer, Emma B.N.J. Janssen, Bas C.T. van Bussel, Laura L.M. Jorissen, Jeanette Tas, Jan-Willem E.M. Sels, Dennis C.J.J Bergmans, Trang H.T. Dinh, Sander M.J. van Kuijk, Anisa Hana, Jannet Mehagnoul-Schipper, Clarissa I.E. Scheeren, Dieter Mesotten, Bjorn Stessel, Gernot Marx, Arnoud W.J.van ´t Hof, Marc E.A. Spaanderman, Walther N.K.A. van Mook, Iwan C.C. van der Horst & Chahinda Ghossein-Doha. (2020) The “sex gap” in COVID-19 trials: a scoping review. EClinicalMedicine 29-30, pages 100652.
Crossref
Crossref
Gaurav S. Dave, Kalpna D. Rakholiya, Mital J. Kaneria, Bhemji P. Galvadiya, Sudhanshu R. Vyas, Vaktabhai H. Kanbi & Manubhai P. Patel. (2020)
High affinity interaction of
Solanum tuberosum
and
Brassica juncea
residue smoke water compounds with proteins involved in coronavirus infection
. Phytotherapy Research 34:12, pages 3400-3410.
Crossref
Crossref
Prasad S. Nishtala, Sakirat Gill & Te‐yuan Chyou. (2020)
Analysis of the
US FDA
adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults
. Pharmacoepidemiology and Drug Safety 29:12, pages 1689-1695.
Crossref
Crossref
Melanie R. Nicol, Abhay Joshi, Matthew L. Rizk, Philip E. Sabato, Radojka M. Savic, David Wesche, Jenny H. Zheng & Jack Cook. (2020) Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection. Clinical Pharmacology & Therapeutics 108:6, pages 1135-1149.
Crossref
Crossref
Donna Austin, Catharine John, Beverley J Hunt & Rachel S. Carling. (2020) Validation of a liquid chromatography tandem mass spectrometry method for the simultaneous determination of hydroxychloroquine and metabolites in human whole blood. Clinical Chemistry and Laboratory Medicine (CCLM) 58:12, pages 2047-2061.
Crossref
Crossref
Siyu Xiu, Alexej Dick, Han Ju, Sako Mirzaie, Fatemeh Abdi, Simon Cocklin, Peng Zhan & Xinyong Liu. (2020) Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. Journal of Medicinal Chemistry 63:21, pages 12256-12274.
Crossref
Crossref
Berat UĞUZ, İ̇smet ZENGİN, Dursun TOPAL, Selvi COŞAR, Selma TİRYAKİOĞLU & Mustafa Adem YILMAZTEPE. (2020) The effects and reliability of the hydroxychloroquine-azithromycin combination on the cardiac conduction system in patients with coronavirus disease 2019. Journal of Surgery and Medicine 4:11, pages 1082-1085.
Crossref
Crossref
Christopher Stremmel, Antonia Kellnar, Steffen Massberg & Stefan Kääb. (2020) Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia. Journal of Cardiovascular Pharmacology and Therapeutics 25:6, pages 497-502.
Crossref
Crossref
Brandon S. Hamm & Lisa J. Rosenthal. (2020) Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae. Psychosomatics 61:6, pages 597-606.
Crossref
Crossref
Z. Khan, D. Ghafoor, A. Khan, D. Ualiyeva, S.A. Khan, H. Bilal, B. Khan, A. Khan & W. Sajjad. (2020) Diagnostic approaches and potential therapeutic options for coronavirus disease 2019. New Microbes and New Infections 38, pages 100770.
Crossref
Crossref
Jeremy P. Berman, Mark P. Abrams, Alexander Kushnir, Geoffrey A. Rubin, Frederick Ehlert, Angelo Biviano, John P. Morrow, Jose Dizon, Elaine Y. Wan, Hirad Yarmohammadi, Marc P. Waase, David A. Rubin, Hasan Garan & Deepak Saluja. (2020) Cardiac electrophysiology consultative experience at the epicenter of the COVID-19 pandemic in the United States. Indian Pacing and Electrophysiology Journal 20:6, pages 250-256.
Crossref
Crossref
Matthew Hooks, Bradley Bart, Orly Vardeny, Anders Westanmo & Selçuk Adabag. (2020) Effects of hydroxychloroquine treatment on QT interval. Heart Rhythm 17:11, pages 1930-1935.
Crossref
Crossref
Özkan Görgülü & Murat Duyan. (2020) rRT-PCR Results of a Covid-19 Diagnosed Geriatric Patient. SN Comprehensive Clinical Medicine 2:11, pages 2423-2426.
Crossref
Crossref
Brian C Hsia, Nicolas Greige, Jose A Quiroz, Ahmed S Khokhar, Johanna Daily, Luigi Di Biase, Kevin J Ferrick, John D Fisher & Andrew Krumerman. (2020) QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin. Journal of Interventional Cardiac Electrophysiology 59:2, pages 337-345.
Crossref
Crossref
Sok‐Sithikun Bun, Philippe Taghji, Johan Courjon, Fabien Squara, Didier Scarlatti, Guillaume Theodore, Delphine Baudouy, Benjamin Sartre, Mohamed Labbaoui, Jean Dellamonica, Denis Doyen, Charles‐Hugo Marquette, Jacques Levraut, Vincent Esnault, Sok‐Siya Bun & Emile Ferrari. (2020) QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection. Clinical Pharmacology & Therapeutics 108:5, pages 1090-1097.
Crossref
Crossref
Roy Guharoy & Edward Krenzelok. (2020) Searching for COVID-19 treatments: First, do no harm. American Journal of Health-System Pharmacy 77:22, pages 1899-1905.
Crossref
Crossref
Ulf Norinder, Astrud Tuck, Kalle Norgren & Vesna Munic Kos. (2020) Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19. Biomedicine & Pharmacotherapy 130, pages 110582.
Crossref
Crossref
Nathalie Cristina Crivelari, Gisele Queiroz de Oliveira, Clarice Hyesuk Lee Park, Gregorio da Cruz Riemma, Isabela Bispo Santos da Silva Costa, Marcus Vinícius Guimarães de Lacerda, Glaucia Maria Moraes de Oliveira, Francisco Carlos da Costa Darrieux, Luciana Sacilotto & Ludhmila Abrahão Hajjar. (2020) Severe Cardiovascular Complications of COVID-19: a Challenge for the Physician. International Journal of Cardiovascular Sciences 33:5, pages 572-581.
Crossref
Crossref
Yu Kang, Hui Wang, Hong Chen, Bo Wang, Yingying Yang, Xuan Zhao, Qihui Ran & Jiafu Wei. (2020) Suspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19. International Heart Journal 61:5, pages 1056-1058.
Crossref
Crossref
Smaragdi Marinaki, Stathis Tsiakas, Maria Korogiannou, Konstantinos Grigorakos, Vassilios Papalois & Ioannis Boletis. (2020) A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients’ Lives and Allografts. Journal of Clinical Medicine 9:9, pages 2986.
Crossref
Crossref
Nicholas J. White, James A. Watson, Richard M. Hoglund, Xin Hui S. Chan, Phaik Yeong Cheah & Joel Tarning. (2020) COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology. PLOS Medicine 17:9, pages e1003252.
Crossref
Crossref
Marco Infante, Camillo Ricordi & Andrea Fabbri. (2020)
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of
COVID
‐19 pandemic
. Journal of Diabetes 12:9, pages 659-667.
Crossref
Crossref
C.C. Prodromos, T. Rumschlag & T. Perchyk. (2020) Hydroxychloroquine is protective to the heart, not harmful: a systematic review. New Microbes and New Infections 37, pages 100747.
Crossref
Crossref
Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad & Hany A. Omar. (2020) Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sciences 257, pages 118054.
Crossref
Crossref
Luis Gabriel Parra-Lara, Juan José Martínez-Arboleda & Fernando Rosso. (2020) Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going. Journal of Global Antimicrobial Resistance 22, pages 680-684.
Crossref
Crossref
Nijad Bakhshaliyev, Mahmut Uluganyan, Asim Enhos, Erdem Karacop & Ramazan Ozdemir. (2020) The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients. Journal of Electrocardiology 62, pages 59-64.
Crossref
Crossref
Ehud Chorin, Lalit Wadhwani, Silvia Magnani, Matthew Dai, Eric Shulman, Charles Nadeau-Routhier, Robert Knotts, Roi Bar-Cohen, Edward Kogan, Chirag Barbhaiya, Anthony Aizer, Douglas Holmes, Scott Bernstein, Michael Spinelli, David S. Park, Carugo Stefano, Larry A. Chinitz & Lior Jankelson. (2020) QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart Rhythm 17:9, pages 1425-1433.
Crossref
Crossref
Shashank Jain, Virginia Workman, Raj Ganeshan, Edinrin R. Obasare, Alicia Burr, Ralph M. DeBiasi, James V. Freeman, Joseph Akar, Rachel Lampert & Lynda E. Rosenfeld. (2020) Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019. Heart Rhythm 17:9, pages 1417-1422.
Crossref
Crossref
John R. Giudicessi, Dan M. Roden, Arthur A.M. Wilde & Michael J. Ackerman. (2020) Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans. Heart Rhythm 17:9, pages 1487-1492.
Crossref
Crossref
Juan Mora-Delgado, Ana Del-Río-Lechuga & Cristina Lojo Cruz. (2020) Abordaje multifactorial del síndrome de QT largo adquirido en la COVID-19. Revista Española de Casos Clínicos en Medicina Interna 5:2, pages 93-95.
Crossref
Crossref
Sweilem Al Rihani, Matt Smith, Ravil Bikmetov, Malavika Deodhar, Pamela Dow, Jacques Turgeon & Veronique Michaud. (2020) Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy. Journal of Clinical Medicine 9:8, pages 2591.
Crossref
Crossref
Ashish Prasad & Manoj Prasad. (2020) Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?. Frontiers in Medicine 7.
Crossref
Crossref
Jacob E. Simmering, Linnea A. Polgreen, Philip M. Polgreen, Rebecca E. Teske, Alejandro P. Comellas & Barry L. Carter. (2020) The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
Crossref
Crossref
Arun R. Sridhar, Neal A. Chatterjee, Basil Saour, Dan Nguyen, Elizabeth A. Starnes, Christine Johnston, Margaret L. Green, Gregory A. Roth & Jeanne E. Poole. (2020) QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019. Heart Rhythm O2 1:3, pages 167-172.
Crossref
Crossref
Li Zou, Lijun Dai, Xingyu Zhang, Zhaohui Zhang & Zhentao Zhang. (2020) Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19. Archives of Pharmacal Research 43:8, pages 765-772.
Crossref
Crossref
Maria Garcia‐Cremades, Belen P. Solans, Emma Hughes, Jacqueline P. Ernest, Erika Wallender, Francesca Aweeka, Anne F. Luetkemeyer & Radojka M. Savic. (2020) Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing. Clinical Pharmacology & Therapeutics 108:2, pages 253-263.
Crossref
Crossref
James A Watson, Joel Tarning, Richard M Hoglund, Frederic J Baud, Bruno Megarbane, Jean-Luc Clemessy & Nicholas J White. (2020) Concentration-dependent mortality of chloroquine in overdose. eLife 9.
Crossref
Crossref
Manikandan Dhanushkodi & Padmaj Kulkarni. (2021) COVID-19 Management: What We Need to Know?. Indian Journal of Medical and Paediatric Oncology 41:04, pages 441-445.
Crossref
Crossref
Samuel L.M. Arnold & Frederick Buckner. (2020) Hydroxychloroquine for Treatment of SARS‐CoV‐2 Infection? Improving Our Confidence in a Model‐Based Approach to Dose Selection. Clinical and Translational Science 13:4, pages 642-645.
Crossref
Crossref
Dan M. Roden, Robert A. Harrington, Athena Poppas & Andrea M. Russo. (2020) Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment. Heart Rhythm 17:7, pages e231-e232.
Crossref
Crossref
Mengmeng Zhao, Menglong Wang, Jishou Zhang, Jing Ye, Yao Xu, Zhen Wang, Di Ye, Jianfang Liu & Jun Wan. (2020) Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomedicine & Pharmacotherapy 127, pages 110230.
Crossref
Crossref
Tan Chen Wu, Luciana Sacilotto, Francisco Carlos da Costa Darrieux, Cristiano Faria Pisani, Sissy Lara de Melo, Denise Tessariol Hachul & Mauricio Scanavacca. (2020) Controle do Intervalo QT para Prevenção de Torsades de Pointes Durante uso de Hidroxicloroquina e/ou Azitromicina em Pacientes com COVID 19. Arquivos Brasileiros de Cardiologia 114:6, pages 1061-1066.
Crossref
Crossref
V. N. Komoliatova & L. M. Makarov. (2020) QT Interval in Patients With COVID-19. Kardiologiia 60:7, pages 11-14.
Crossref
Crossref
V. I. Stashkiv, K. A. Zamyatina, M. Yu. Shantarevich, I. V. Nikitina, G. G. Kаrmаzаnovsky & A. Sh. Revishvili. (2020) CT findings in patients with COVID-19 pneumonia after treatment with tocilizumab: foreign literature review. Medical Visualization 24:2, pages 96-104.
Crossref
Crossref
Dan M. RodenRobert A. HarringtonAthena PoppasAndrea M. Russo. (2020) Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment. Circulation 141:24.
Crossref
Crossref
Anand Prakash Singh, Sultan Tousif, Prachi Umbarkar & Hind Lal. (2020) A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation. Journal of Clinical Medicine 9:6, pages 1867.
Crossref
Crossref
Moussa Saleh, James Gabriels, David Chang, Beom Soo KimAmtul Mansoor, Eitezaz MahmoodParth Makker, Haisam IsmailBruce Goldner, Jonathan WillnerStuart BeldnerRaman Mitra, Roy JohnJason ChinitzNicholas Skipitaris, Stavros MountantonakisLaurence M. Epstein. (2020) Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Circulation: Arrhythmia and Electrophysiology 13:6.
Crossref
Crossref
Laure ElensLoralie J. LangmanDennis A. HesselinkStein BerganDirk Jan A.R. MoesMariadelfina MolinaroRaman VenkataramananFlorian Lemaitre. (2020) Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions. Therapeutic Drug Monitoring 42:3, pages 360-368.
Crossref
Crossref
Ronald Brown. (2020) Hydroxychloroquine and “off-label” utilization in the treatment of oral conditions. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 129:6, pages 643-644.
Crossref
Crossref
John R. Giudicessi, Peter A. Noseworthy, Paul A. Friedman & Michael J. Ackerman. (2020) Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clinic Proceedings 95:6, pages 1213-1221.
Crossref
Crossref
David Chang, Moussa Saleh, James Gabriels, Haisam Ismail, Bruce Goldner, Jonathan Willner, Stuart Beldner, Raman Mitra, Roy John & Laurence M. Epstein. (2020) Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin. Journal of the American College of Cardiology 75:23, pages 2992-2993.
Crossref
Crossref
Giuseppe Annunziata, Marco Sanduzzi Zamparelli, Ciro Santoro, Roberto Ciampaglia, Mariano Stornaiuolo, Gian Carlo Tenore, Alessandro Sanduzzi & Ettore Novellino. (2020) May Polyphenols Have a Role Against Coronavirus Infection? An Overview of in vitro Evidence. Frontiers in Medicine 7.
Crossref
Crossref
Anwar M. Hashem, Badrah S. Alghamdi, Abdullah A. Algaissi, Fahad S. Alshehri, Abdullah Bukhari, Mohamed A. Alfaleh & Ziad A. Memish. (2020) Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review. Travel Medicine and Infectious Disease 35, pages 101735.
Crossref
Crossref
Dan M. Roden, Robert A. Harrington, Athena Poppas & Andrea M. Russo. (2020) Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment. Journal of the American College of Cardiology 75:20, pages 2623-2624.
Crossref
Crossref
James Gabriels, Moussa Saleh, David Chang & Laurence M. Epstein. (2020) Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin. HeartRhythm Case Reports 6:5, pages 241-243.
Crossref
Crossref
Christian Funck-Brentano, Joe-Elie Salem, Lee S. Nguyen, Milou-Daniel Drici & Dan M. Roden. (2020) Response to the editorial “COVID-19 in patients with cardiovascular diseases”. Archives of Cardiovascular Diseases 113:5, pages 367-368.
Crossref
Crossref
Jerry L. Bauman & James E. Tisdale. (2020) Chloroquine and Hydroxychloroquine in the Era of SARS – CoV2: Caution on Their Cardiac Toxicity. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:5, pages 387-388.
Crossref
Crossref
Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Valery Lavergne, Lindsey Baden, Vincent Chi-Chung Cheng, Kathryn M Edwards, Rajesh Gandhi, William J Muller, John C O’Horo, Shmuel Shoham, M Hassan Murad, Reem A Mustafa, Shahnaz Sultan & Yngve Falck-Ytter. (2020) Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases.
Crossref
Crossref
Berna TERZİOĞLU BEBİTOĞLU, Elif OĞUZ, Ajla HODZİC, Nebile HATİBOĞLU & Özkan KAM. (2020) Klorokin/Hidroksiklorokin: COVID-19 tedavisi ile gündeme gelen eski bir ilaca farmakolojik bakışChloroquine / Hydroxychloroquine: Pharmacological view of an old drug currently used in COVID-19 treatment. Anadolu Kliniği Tıp Bilimleri Dergisi 25:Special Issue on COVID 19, pages 204-215.
Crossref
Crossref
Rimesh Pal, Mainak Banerjee, Ashok Kumar & SanjayKumar Bhadada. (2020) Glycemic efficacy and safety of hydroxychloroquine in type 2 diabetes mellitus: A systematic review and meta.analysis of relevance amid the COVID-19 pandemic. International Journal of Noncommunicable Diseases 5:4, pages 184.
Crossref
Crossref
Pietro Enea Lazzerini, Franco Laghi-Pasini, Nabil El-Sherif, Mohamed Boutjdir & Pier Leopoldo Capecchi. 2020. Cardiac Repolarization. Cardiac Repolarization
227
251
.
Sophie I. Mavrogeni, George Markousis-Mavrogenis, Constantina Aggeli, Dimitris Tousoulis, George D. Kitas, Genovefa Kolovou, Efstathios K. Iliodromitis & Petros P. Sfikakis. (2019) Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology. Diagnostics 9:4, pages 217.
Crossref
Crossref
Clotilde Chatre, François Roubille, Hélène Vernhet, Christian Jorgensen & Yves-Marie Pers. (2018) Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. Drug Safety 41:10, pages 919-931.
Crossref
Crossref
F R Spinelli, E Moscarelli, F Ceccarelli, F Miranda, C Perricone, S Truglia, C Garufi, L Massaro, F Morello, C Alessandri, G Valesini & F Conti. (2018) Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort. Lupus 27:10, pages 1616-1623.
Crossref
Crossref
C. Merino Argumánez, I. Sáez de La Fuente, Z. Molina Collado, D. Suárez Pita, B. Mestre Gómez & J.A. Sanchez Izquierdo. (2017) Hydroxychloroquine, a potentially lethal drug. Medicina Intensiva (English Edition) 41:4, pages 257-259.
Crossref
Crossref
C. Merino Argumánez, I. Sáez de La Fuente, Z. Molina Collado, D. Suárez Pita, B. Mestre Gómez & J.A. Sanchez Izquierdo. (2017) La hidroxicloroquina, un fármaco potencialmente letal. Medicina Intensiva 41:4, pages 257-259.
Crossref
Crossref
M. Imazio, S. Maestroni, A. Valenti, V. Ramoni & A. Brucato. 2017. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases
617
643
.
John P. O?Laughlin, Parag H. Mehta & Brian C. Wong. (2016) Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine. Case Reports in Cardiology 2016, pages 1-4.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
253
267
.
Md. Abdul Alim Al-Bari. (2015) Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. Journal of Antimicrobial Chemotherapy 70:6, pages 1608-1621.
Crossref
Crossref
Pietro Enea Lazzerini, Pier Leopoldo Capecchi & Franco Laghi-Pasini. (2015) Long QT Syndrome: An Emerging Role for Inflammation and Immunity. Frontiers in Cardiovascular Medicine 2.
Crossref
Crossref
Sarah Braun, Marion Ferner, Kai Kronfeld & Matthias Griese. (2015) Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases. Pediatric Pulmonology 50:4, pages 410-419.
Crossref
Crossref
Megha Prasad, Joerg Hermann, Sherine E. Gabriel, Cornelia M. Weyand, Sharon Mulvagh, Rekha Mankad, Jae K. Oh, Eric L. Matteson & Amir Lerman. (2014) Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nature Reviews Cardiology 12:3, pages 168-176.
Crossref
Crossref
Paul B. McBeth, Perseus I. Missirlis, Harry Brar & Vinay Dhingra. (2015) Novel Therapies for Myocardial Irritability following Extreme Hydroxychloroquine Toxicity. Case Reports in Emergency Medicine 2015, pages 1-4.
Crossref
Crossref
A Nandagudi, EC Jury, D Alonzi, TD Butters, S Hughes & DA Isenberg. (2013) Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry?s disease. Lupus 22:10, pages 1070-1076.
Crossref
Crossref
Emer Joyce, Aurelie Fabre & Niall Mahon. (2012) Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. European Heart Journal: Acute Cardiovascular Care 2:1, pages 77-83.
Crossref
Crossref
C. Tang, T. Godfrey, R. Stawell & M. Nikpour. (2012) Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects. Internal Medicine Journal 42:9, pages 968-978.
Crossref
Crossref
Christopher Newton-Cheh, Angela E. Lin, Aaron L. Baggish & He Wang. (2011) Case 11-2011. New England Journal of Medicine 364:15, pages 1450-1460.
Crossref
Crossref
Erez Ben-Menachem. (2010) Systemic Lupus Erythematosus. Anesthesia & Analgesia 111:3, pages 665-676.
Crossref
Crossref
Jose-Luis Ayensa, Munther Khamashta & Guillermo Ruiz-Irastorza. (2010) A new role for antimalarials in systemic lupus erythematosus treatment. International Journal of Clinical Rheumatology 5:3, pages 299-312.
Crossref
Crossref
. 2010. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs
371
667
.
. 2010. Meyler's Side Effects of Antimicrobial Drugs. Meyler's Side Effects of Antimicrobial Drugs
777
932
.
Oscar Ozmund Simooya. 2009.
469
476
.
John N. Makaryus, John N. Catanzaro, Steven Goldberg & Amgad N. Makaryus. (2008) Rapid progression of atrioventricular nodal blockade in a patient with systemic lupus erythematosus. The American Journal of Emergency Medicine 26:8, pages 967.e5-967.e7.
Crossref
Crossref
Dimitrios A. Pappas, Janis M. Taube, Joan M. Bathon & Jon T. Giles. (2008) A 73‐year‐old woman with rheumatoid arthritis and shortness of breath. Arthritis Care & Research 59:6, pages 892-899.
Crossref
Crossref
Christian A Pineau, Chin Lee, Rosalind Ramsey-Goldman, Ann E Clarke & Sasha Bernatsky. (2007) The second hit: comorbidities in systemic lupus erythematosus. Future Rheumatology 2:5, pages 497-506.
Crossref
Crossref
P. M. Seferović, A. D. Ristić, R. Maksimović, D. S. Simeunović, G. G. Ristić, G. Radovanović, D. Seferović, B. Maisch & M. Matucci-Cerinic. (2006) Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology 45:suppl_4, pages iv39-iv42.
Crossref
Crossref